
2.14BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00847X1046
CUSIP
00847X104
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
20.41
Dividend Share
-
Dividend Yield
-
Earnings Share
-6.79
Wall Street Target Price
43.13
EPS Estimate Current Year
-6.14
EPS Estimate Next Year
-4.63
EPS Estimate Current Quarter
-1.7871
EPS Estimate Next Quarter
-1.7073
Most Recent Quarter
-
Revenue TTM
66,048,000
Gross Profit TTM
-288,471,008
EBITDA
-470,265,984
Profit Margin
0.00%
Return On Assets TTM
-21.69%
Return On Equity TTM
-32.81%
Revenue Per Share TTM
1.133
Qtly Revenue Growth YOY
137.70%
Diluted Eps TTM
-6.79
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
2
Price Sales TTM
29.4891
Price Book MRQ
0.857
Enterprise Value Revenue
30
Enterprise Value EBITDA
-2
760.00
3.03%22.75
2.52%865.00
0.00%88.94
0.00%124.85
-12.62%259.59
-12.18%853.82
-2.26%187.48
-2.14%476.99
-0.98%204.11
-0.83%